Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD.
HbA1c
Type 2 diabetes
chronic kidney disease
continuous glucose monitoring
diagnostic test study
glycated hemoglobin
Journal
Kidney medicine
ISSN: 2590-0595
Titre abrégé: Kidney Med
Pays: United States
ID NLM: 101756300
Informations de publication
Date de publication:
Historique:
entrez:
1
8
2020
pubmed:
1
8
2020
medline:
1
8
2020
Statut:
epublish
Résumé
The accuracy of glycated hemoglobin (HbA Diagnostic test study of HbA Patients with type 2 diabetes and CKD (estimated glomerular filtration rate, 7-45 mL/min, not receiving dialysis) seen in an academic nephrology clinic. The accuracy of HbA The degree of correlation between continuous glucose monitoring-derived average glucose concentration and HbA 80 patients wore the continuous glucose monitor for a mean of 12.7 ± 2.9 days. Average glucose concentration of all patients was 151.5 ± 55.7 mg/dL. Mean HbA Relatively small sample size. HbA
Identifiants
pubmed: 32734208
doi: 10.1016/j.xkme.2019.07.006
pii: S2590-0595(19)30085-8
pmc: PMC7380426
doi:
Types de publication
Journal Article
Langues
eng
Pagination
281-287Informations de copyright
© 2019 Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.
Références
Diabetes Care. 2008 Aug;31(8):1473-8
pubmed: 18540046
Diabetes Care. 2007 Jan;30 Suppl 1:S4-S41
pubmed: 17192377
JAMA. 2006 Apr 12;295(14):1688-97
pubmed: 16609091
Ann Clin Biochem. 1992 Mar;29 ( Pt 2):206-9
pubmed: 1626926
Blood Purif. 2017;43(1-3):200-205
pubmed: 28114136
Horm Metab Res Suppl. 1992;26:59-62
pubmed: 1490693
Diabetes Technol Ther. 2018 Apr;20(4):314-316
pubmed: 29565197
Clin Chem. 1999 Mar;45(3):438-40
pubmed: 10053058
Diabetes Care. 2004 Jul;27(7):1761-73
pubmed: 15220264
Rev Clin Esp. 2018 Aug - Sep;218(6):305-315
pubmed: 29691065